SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001193125-24-058723
Filing Date
2024-03-05
Accepted
2024-03-05 08:22:00
Documents
11
Effectiveness Date
2024-03-05

Document Format Files

Seq Description Document Type Size
1 S-3ASR d932983ds3asr.htm S-3ASR 430201
2 EX-4.3 d932983dex43.htm EX-4.3 345185
3 EX-4.4 d932983dex44.htm EX-4.4 334072
4 EX-4.5 d932983dex45.htm EX-4.5 34934
5 EX-4.6 d932983dex46.htm EX-4.6 34790
6 EX-5.1 d932983dex51.htm EX-5.1 32935
7 EX-23.1 d932983dex231.htm EX-23.1 1548
8 EX-FILING FEES d932983dexfilingfees.htm EX-FILING FEES 51839
9 GRAPHIC g932983g0228101727217.jpg GRAPHIC 1638
10 GRAPHIC g932983g0228101727432.jpg GRAPHIC 7169
11 GRAPHIC g932983g69s52.jpg GRAPHIC 41185
  Complete submission text file 0001193125-24-058723.txt   1331589
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-277655 | Film No.: 24718380
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)